Accelerated Phase Chronic Myelogenous Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
C
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia",
Recruiting
  • Philadelphia Chromosome Positive CML
  • +3 more
  • Birmingham, Alabama
  • +40 more
2022-02-28
Feb 28, 2022
S
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +67 more
  • Fludarabine phosphate
  • +8 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2021-08-31
Aug 31, 2021
I
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey - 2021
Completed
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
    • Limerick, Dooradoyle, Ireland
    • +32 more
    2021-08-13
    Aug 13, 2021
    F
    Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +23 more
    • Denver, Colorado
    • +2 more
    2021-06-17
    Jun 17, 2021
    F
    Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
    Completed
    • Hematopoietic/Lymphoid Cancer
    • +135 more
    • beclomethasone dipropionate
    • +4 more
    • Hackensack, New Jersey
    • +1 more
    2021-02-01
    Feb 1, 2021
    F
    Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer - 2018
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +173 more
    • fludarabine phosphate
    • +6 more
    • Salt Lake City, Utah
    • +4 more
    2020-01-17
    Jan 17, 2020
    F
    Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant
    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +134 more
    • fludarabine phosphate
    • +6 more
    • Stanford, California
    • +9 more
    2020-01-15
    Jan 15, 2020
    R
    Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders - 2019
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +99 more
    • fludarabine phosphate
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    2019-10-30
    Oct 30, 2019
    R
    Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies - 2019
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +77 more
    • fludarabine phosphate
    • +8 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    2019-09-16
    Sep 16, 2019
    F
    Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +44 more
    • fludarabine phosphate
    • +9 more
    • Duarte, California
    • +6 more
    2019-09-06
    Sep 6, 2019
    U
    Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies - 2018
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +63 more
    • therapeutic allogeneic lymphocytes
    • laboratory biomarker analysis
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    2019-07-17
    Jul 17, 2019
    C
    Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload - 2011
    Terminated
    Has Results
    • Iron Overload
    • +101 more
    • Duarte, California
      City of Hope
    2019-06-07
    Jun 7, 2019
    C
    Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant - 2013
    Completed
    • Hematopoietic/Lymphoid Cancer
    • +153 more
    • infection prophylaxis and management
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    2019-04-24
    Apr 24, 2019
    N
    Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies - 2014
    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +19 more
    • umbilical cord blood transplantation
    • +7 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2019-02-27
    Feb 27, 2019
    U
    Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer - 2014
    Terminated
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +110 more
    • Omaha, Nebraska
      University of Nebraska Medical Center
    2019-02-06
    Feb 6, 2019
    N
    Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies - 2014
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +117 more
    • Ann Arbor, Michigan
      University of Michigan University Hospital
    2018-06-28
    Jun 28, 2018
    W
    Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer - 2012
    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +86 more
    • massage therapy
    • +4 more
    • Winston-Salem, North Carolina
      Wake Forest University Health Sciences
    2018-06-29
    Jun 29, 2018
    C
    Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant - 2011
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +24 more
    • Birmingham, Alabama
    • +25 more
    2017-09-01
    Sep 1, 2017
    F
    Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML - 2013
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +13 more
    • Stanford, California
    • +4 more
    2017-07-11
    Jul 11, 2017
    F
    Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies - 2011
    Terminated
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +82 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2017-06-26
    Jun 26, 2017
    F
    Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +178 more
    • fludarabine phosphate
    • +5 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2017-04-17
    Apr 17, 2017
    F
    Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant - 2009
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +103 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2017-04-20
    Apr 20, 2017
    F
    Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies - 2015
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +67 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2017-05-17
    May 17, 2017
    F
    Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer - 2014
    Completed
    Has Results
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +96 more
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center/University of Washington
    2017-04-10
    Apr 10, 2017